Navigation Links
Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
Date:7/5/2012

SAN DIEGO, July 5, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the promotion of Craig M. Audet to the position of Senior Vice President, Operations and Head of Global Regulatory Affairs. In his new role, Audet will serve as an executive officer of the company.

Audet, 48, will oversee various operations at Arena, including investor relations and alliance management, and will continue to lead regulatory affairs. He joined the company in April 2011 as Vice President, Regulatory Affairs, and has led Arena's interactions with the US Food and Drug Administration (FDA) and European Medicines Agency (EMA). On June 27, 2012, the FDA approved Arena's internally discovered and developed drug, BELVIQ (lorcaserin hydrochloride), as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m(2) or greater (obese), or 27 kg/m(2) or greater (overweight) in the presence of at least one weight related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes). The lorcaserin Marketing Authorization Application (MAA) is under review by the EMA.

"This promotion recognizes Craig's key role in the FDA's approval of BELVIQ," said Jack Lief, Arena's President and Chief Executive Officer. "We have benefited from his experience and track record of successful regulatory strategies and submissions, and we are delighted that he will play an expanded role in advancing Arena in the next phase of the company's development."

Audet added, "Arena has made significant progress to date, and I am honored to continue working alongside the talented team in this new capacity. It is exciting to be part of an innovative company with both a promising pipeline and validated technology. I look forward to playing a key role at Arena as we continue
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
2. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
3. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
5. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
6. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
7. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
8. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
9. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
10. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
11. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 Bloomage BioTechnology ... announces a strategic cooperation with the South Korean BioTech ... a joint venture Medybloom to develop and promote Type ... China . Medytox, the Botulinum ... and is also the fourth company in the world ...
(Date:7/27/2015)... , July 27, 2015   DocResponse ... technology application in a peer-reviewed study , ... triage: audit study", published in the July issue ... study by Harvard Medical School researchers determined that ... DocResponse listing the correct diagnosis first in standardized ...
(Date:7/27/2015)... , Belgium , July 27, ... VNRX), a life sciences company focused on developing blood-based ... and other conditions, today announced that it has engaged ... organization, Global Specimen Solutions, Inc. (GSS), to support initial ... cancer tests. Under the agreement, GSS ...
Breaking Medicine Technology:Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7
... CVM ) announces that its CEL-1000 immunomodulator was ... against the recombinant hepatitis B,virus protein more quickly than ... was seen within 14 days, most pronounced with a ... up to a 40% increase in antibody,signal at day ...
... Ontario, Sept. 19 ArtJen Complexus Holdings,Corp. (http://www.fbcx.com ... trial with obese type 2 diabetics and an animal ... studied by a major US,west-coast university medical center. The ... fiber that binds dietary fat will involve,overweight but not ...
Cached Medicine Technology:CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein 2CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein 3ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx 2
(Date:7/27/2015)... ... ... With a new charity program in the Chico, CA area, Gary Short & ... of deaths and injuries occurring from police pursuits, and announced that they will be ... police to find better and safer ways to conduct pursuits. To support this wonderful ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they ... that tooth loss can incur a lot of stress, pain, discomfort and embarrassment, which ... The All-On-4™ treatment reaps the benefits of implants with the cost savings of ...
(Date:7/27/2015)... ... , ... In a creative effort to provide clear information about the process ... at Dove Tree in Lubbock has shared a new infographic to illustrate the process. ... Both the nationally recognized collegiate program and traditional adult program at The Ranch at ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... SupplyLogic, a ... executive blog on its newly redesigned company Website. In the blog, Founder and CEO ... of a popular comedian: "Comedian George Wallace always asks: ‘Why is it the closer ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... serving communities in and around Dallas, Texas, is announcing a joint charity effort ... support and employment resources for American veterans who are returning from overseas. , ...
Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3Health News:SupplyLogic Releases First Executive Blog on Supply Chain Management Issues 2Health News:The Tedesco Agency of North Dallas and Non-Profit IAVA Announce Joint Charity Effort to Support American Veterans 2
... ... Angeles and Torrance, California area, is giving back to the community with an Evening of ... - a husband and wife who will discuss their successful procedures, as well as a demonstration ... ...
... , ... ... , , , , ... ...
... ... ... ... ...
... ... ... , ... , , , ...
... ... ... ... ...
... who do it appear to have difficulty coping in a ... -- People who grind their teeth at night appear to ... to use escapism to cope when things become difficult, new ... Giraki, of Heinrich-Heine-University in Dusseldorf, studied 48 people who were ...
Cached Medicine News:Health News:Los Angeles Plastic Surgeon Christine Petti, MD Gives Patients an Evening of Beauty 2Health News:Los Angeles Plastic Surgeon Christine Petti, MD Gives Patients an Evening of Beauty 3Health News:KID HEALTHY-Steps to Healthy Living Kicks Off 2010 Campaign to Make Southern California Kids and Families Healthier 2Health News:KID HEALTHY-Steps to Healthy Living Kicks Off 2010 Campaign to Make Southern California Kids and Families Healthier 3Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 4Health News:BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 5Health News:Global AIDS Alliance: U.S. Must Meet Its Obligations to Family Planning 2Health News:Global AIDS Alliance: U.S. Must Meet Its Obligations to Family Planning 3Health News:Blue Cross and Blue Shield of Minnesota Foundation Announces Funding Opportunity 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Announces Funding Opportunity 3Health News:Blue Cross and Blue Shield of Minnesota Foundation Announces Funding Opportunity 4Health News:Grinding Teeth at Night May Be a Sign of Daytime Stress 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: